Estonia will be the first in Japan to receive an experimental drug for COVID-19 for research



[ad_1]

“The fact that Estonia receives Avigan medicines from Japan is a very good example of international cooperation in a crisis. On Thursday, I spoke to my Japanese colleague Toshimitsu Motegi and thanked him,” said Estonian Foreign Minister Urmas Reinsalu.

Avigan was developed by the Japanese pharmaceutical company Fujifilm Toyama Chemicals as a flu medicine. Following the coronavirus outbreak in Estonia, Tallinn was interested in the theoretical possibility of treating COVID-19 patients with this drug.

More than 80 countries have asked Japan to send Avigan for research and experimental treatment. Tokyo agreed to share the drug free of charge for international cooperation. Estonia, meanwhile, has committed to providing Japan with the results of clinical trials, the MFA said.

It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on the Internet without the written consent of UAB “BNS”.



[ad_2]